DEPRESSION, ANXIETY AND STRESS AMONG THE PATIENT OF CHRONIC KIDNEY DISEASE AT NADIAD CITY, A CROSS SECTIONAL SURVEY

PDF

Published: 2021-09-18

Page: 240-244


KAILASH NAGAR *

Department of Community Health Nursing, Dinsha Patel College of Nursing, Nadiad, India.

*Author to whom correspondence should be addressed.


Abstract

Introduction: Chronic kidney disease is considered a public health problem worldwide. It is defined by kidney tissue injury [with or without a decrease in glomerular filtration rate and /or a decrease in kidney function over a period of three or more months. When the glomerular filtration rate [GFR] is below 15ml./min./1.73m2, the patient is in the terminal stage of dialysis, requiring renal replacement therapy [RRT], dialysis, or transplant as alternative treatments. Renal failure is the inability of the kidney to excrete wastes, concentrate urine, and conserve electrolytes. Renal failure is precipitated by a variety of etiological factors. It is treatable but not curable, which means that the patient needs long-term therapy or transplantation.

The overall prevalence of depression, anxiety, and stress in this study was found to be 22.9%, 19.2%, and 28.2%, respectively. Forty nine (13.84%) respondents had mild depression twenty eight (7.91%) has moderate depression.

Depression and anxiety are frequent comorbid disorders among chronic kidney disease (CKD) patients, with an estimated prevalence of approximately 25% in this population, [1] and are associated with worse outcomes, such as progression to end-stage renal disease (ESRD) and mortality [2,3,4,5]. The transition from predialysis management to renal replacement therapy (RRT) is a stressful event in the course of CKD, leading to challenges and decisions that might increase their susceptibility to anxiety, mood disorders or even exacerbate psychological issues that already exist [6].

Aims: The researcher aim to assess the level of depression, anxiety and stress among chronic kidney disease patient in selected hospital of Nadiad City, Gujarat. The research wants to explore the actual psychological status of the patients who were suffering from chronic illness like CKD, because due to long-term suffering from the illness disturbed everyone mind and cause various psychological changes in the body. Hence research wants to assess what kind of changes take place due to chronic kidney diseases.

Objectives:- 1) To assess the level of depression among CKD patients at a selected hospital, Nadiad.

2) To assess the level of anxiety among CKD patients at selected hospital, Nadiad.

3) To assess the level of stress among the CKD patients at selected hospital, Nadiad.

Methodology:

Design and Setting: Descriptive cross sectional survey research design was adopted for the study and a non-probability purposive sampling method was used to drawn samples from the participants. For the data collection researcher has used modified The DASS-42 is a 42 item self-report scale designed to measure the negative emotional states of depression, anxiety and stress, it is a standardized tool.

Prior to data collection written setting permission obtain from the head of the hospital as well as prior informed consent form was obtain from the study participants, the objectives and methods of the study were appropriately explain to the samples. For data collection researcher has select MPUH kidney hospital situated Nadiad City. The total sample size was 30 chronic kidney disease patients.

The research data collection tool consists of the following Section I Demographic variables of the CKD patients section II DASS 42 questionnaire self-rating scale.

Statistical Analysis: Descriptive statistics were applied where, data were analyzed by using SPSS software, and Frequency, percentage, tables, etc. were used to represent the statistical data in the tables and graphs and figures.

Results: The majority of participants (30%) were 41-50 years, sample (36.67%) belong, age group of above 50 years, majority 56.67% were Male, (43.33%) were graduate, (67%) Having 5000-10000 Monthly Income, (60%) were living in Joint family, (56.67%) were belong to 0-3 years, (23.33%) were belong above 9 years if illness. Duration of hospitalization (80%) 0-15 days.

The prevalence rate of depression, anxiety, and stress among Chronic Kidney Disease the most of patients have 50% had moderate symptoms of depression, anxiety, and stress, 30% had mild and only 20% have severe symptoms of depression, anxiety, and stress which was measured by DASS self-rating scale.

Conclusions: the currents study ended to assess the prevalence rate of depression, anxiety, and stress among Chronic Kidney Disease patients, the study result concluded that the majority (50%) of Patients having a moderate level of depression, anxiety, and stress. The people in the age group 41-50 or above 50 are having a higher rate of depression, anxiety, and stress during chronic kidney disease.

Keywords: CKD, WHO, Renal, GFR, RRT, DASS


How to Cite

NAGAR, K. (2021). DEPRESSION, ANXIETY AND STRESS AMONG THE PATIENT OF CHRONIC KIDNEY DISEASE AT NADIAD CITY, A CROSS SECTIONAL SURVEY. Asian Journal of Advances in Medical Science, 3(1), 240–244. Retrieved from https://mbimph.com/index.php/AJOAIMS/article/view/2473

Downloads

Download data is not yet available.

References

Aatir H. Rajput, Maryam Sheikh, Sooraj Kumar. Depression, anxiety and stress among patients of end stage renal disease undergoing. Hemodialysis. 2017;4.

ISSN: 2412-3188.

Shervin Assari. Chronic kidney disease and depression and anxiety among American Blacks; Does Ethnicity Matter? 2014;133- 139.

Amirtha Santhi S, Rebecca Samson, Srikanth, Pethuru D. Effectiveness of physical activity on depression, anxiety, stress and quality of life of patients on hemodialysis. Biomedical Research. 2018;29(9):1885-1890.

Mollahadi M. BSc, Tayyebi A. MSc, Ebadi A. PhD, Daneshmandi M. MSc. Comparison of anxiety, depression, stress among Hemodialysis and Kidney transplantation patients. Winter. 2010;2(4):153-156.

Cicero ltaio L. Benzerra, Bruno C. Silva, Rosilene M. Elias. Decision-making process in the pre-dialysis Chronic kidney disease patients: do anxiety, stress and depression matter? Bezerra et al. BMC Nephrology. 2018; 19:98.

Vincy Nelson, Sreedas Gopalkrishna, Rakesh PS, Sony Simon, Vibeesh Babu, Yumna Mohammed. Department of community medicine, Travancore Medical College, Kollam, India, Depression among Dialysis Patients. 2010;40.

Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007 Aug;72(3):247-59.

DOI: 10.1038/sj.ki.5002343. Epub 2007 Jun 13.

PMID: 17568785.

Available:https://pubmed.ncbi.nlm.nih.gov/17568785/

Vaidya SR, Aeddula NR. Chronic Renal Failure. [Updated 2021 Jul 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.

Available:https://www.ncbi.nlm.nih.gov/books/NBK535404/

Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3(1):19-62.

DOI:10.1038/kisup.2012.64

Available:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089693/

Verma S, Mishra A. Depression, anxiety, and stress and socio-demographic correlates among general Indian public during COVID-19. Int J Soc Psychiatry. 2020;66(8):756-762.

DOI: 10.1177/0020764020934508. Epub 2020 Jun 20. PMID: 32567466.

Available:https://pubmed.ncbi.nlm.nih.gov/32567466/

DASS self rating scale.

Available:https://maic.qld.gov.au/wp-content/uploads/2016/07/DASS-21.pdf

Kailash Nagar, Assess The Attitude Regarding Online Lecture Among Nursing College Students After Impact of Covid-19, Medrxiv publication, [Internet].

DOI: https://doi.org/10.1101/2021.07.01.21259132

Suthar DB, Nagar K. A Study To Assess The Effectiveness Of Planned Teaching Programme On Prevention Of Selected Life Style Diseases In Terms Of Knowledge And Attitude Among Male Adults At Selected PHC Of Kheda District. Indian J Forensic Med Toxicol. 2021;15(3):15732.

DOI: 10.37506/ijfmt.v15i3.15732.

PMID: 34434007.

Available:https://pubmed.ncbi.nlm.nih.gov/34434007/